InsiderClue
← All stocks

ARTIVION, INC.

AORT Net selling
CIK 0000784199 #2312 in the set updated 17 Sep 2026
Bought (120 mo)
$774.03K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$66.32M
$1.52M on a plan · $34.13M straight out of an exercise
Sold at will
$30.67M
228 of 329 sales
Net
−$65.54M
−$29.90M against sales at will

By person

33 insiders · 344 transactions
26.2×

J. Patrick Mackin holds 26.2 times base salary in stock. $21.91M of shares against $835.15K in salary for 2025.

Salary from the company's own proxy. The shares are what J. Patrick Mackin last reported holding, valued at $24.97, the price Common Stock was last bought or sold at on the open market here, on 10 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Mackin James P
President & CEO
$117.36K (1)
$29.72M (41)
−$29.60M
877,275
1.80%
$21.91M
+139.0%
Holloway Jean F
SVP, General Counsel
—
$7.82M (54) scheduled
−$7.82M
184,118
0.3776%
$4.60M
+368.8%
Stanton Marshall S.
SVP, Clinical & MD Affair
—
$6.07M (35) scheduled
−$6.07M
60,097
0.1233%
$1.50M
+868.4%
LEE DAVID ASHLEY
Executive VP, COO & CFO
—
$4.99M (14) scheduled
−$4.99M
394,217
0.8085%
$9.84M
+29.9%
Davis John E
Chief Commercial Officer
$176.86K (2)
$4.48M (37) scheduled
−$4.31M
230,794
0.4734%
$5.76M
+643.8%
Horton Amy
VP, Chief Accounting Officer
—
$4.23M (43) scheduled
−$4.23M
139,088
0.2853%
$3.47M
+82.8%
GREEN ANDREW M
SVP, Regulatory and Quality
—
$1.88M (16) scheduled
−$1.88M
40,160
0.0824%
$1.00M
+49.9%
McCall Ronald D
Director
—
$1.32M (15)
−$1.32M
137,768
0.2826%
$3.44M
−18.6%
Berry Lance A
EVP, COO, CFO & Treasurer
—
$1.01M (7)
−$1.01M
210,112
0.4309%
$5.25M
—
RONALD C ELKINS
Director
—
$1.01M (12)
−$1.01M
64,843
0.1330%
$1.62M
−36.8%
Maier Dennis B
SVP, Operations
—
$813.80K (16)
−$813.80K
34,724
0.0712%
$867.06K
+239.8%
Capps Scott B
VP, Clinical Research
—
$812.46K (5) scheduled
−$812.46K
153,203
0.3142%
$3.83M
+54.1%
Getz Matthew A
VP, Human Resources
—
$575.72K (13)
−$575.72K
34,116
0.0700%
$851.88K
+103,282%
Gale David C
VP, Research & Development
—
$392.50K (2) scheduled
−$392.50K
77,135
0.1582%
$1.93M
+11.5%
MORGAN HARVEY
Director
—
$325.43K (3)
−$325.43K
220,802
0.4529%
$5.51M
+6.5%
Maney Rochelle L.
VP, Quality
—
$275.76K (9)
−$275.76K
46,536
0.0954%
$1.16M
+215.7%
Hoff Elizabeth A
Director
—
$189.41K (1)
−$189.41K
34,765
0.0713%
$868.08K
—
Bullock James
Director
$166.27K (1)
—
+$166.27K
76,223
0.1563%
$1.90M
+2,438%
Benson James
Director
—
$45.60K (1)
−$45.60K
54,086
0.1109%
$1.35M
−15.6%
Tyrs Florian
VP, Global Operations
—
$29.52K (3)
−$29.52K
21,558
0.0442%
$538.30K
+49.8%
SEMEDO ANTHONY B.
Director
$313.54K (3)
$316.66K (2)
−$3.11K
46,960
0.0963%
$1.17M
—
BEVEVINO DANIEL J
Director
—
—
—
157,637
0.3233%
$3.94M
+67.5%
ACKERMAN THOMAS F
Director
—
—
—
157,472
0.3230%
$3.93M
+67.4%
Salveson Jon W
Director
—
—
—
137,416
0.2818%
$3.43M
+85.5%
Burbank Jeffrey H
Director
—
—
—
61,372
0.1259%
$1.53M
+1,641%
Borgstrom Marna P
Director
—
—
—
56,938
0.1168%
$1.42M
—
Matthews William Robert
Senior VP, Operations, Quality
—
—
—
39,883
0.0818%
$995.88K
+110.2%
Simpson Michael S
SVP, Regulatory Affairs and QA
—
—
—
33,698
0.0691%
$841.44K
+184.9%
Barthold Franz Peter
VP, Research & Development
—
—
—
32,516
0.0667%
$811.92K
+369.0%
McDermid James M
SVP, CHRO
—
—
—
30,806
0.0632%
$769.23K
+616.1%
Saurini Sherry M
VP, Quality
—
—
—
25,084
0.0514%
$626.35K
−4.2%
Bogenschuetz Thomas J
VP, EMEA & General Manager
—
—
—
23,451
0.0481%
$585.57K
+76.2%
THOMSON ROBERT C
VP Research & Development
—
—
—
13,291
0.0273%
$331.88K
—

Individual transactions

52
Insider
Date
Role
Action
Shares
Price
Amount
GREEN ANDREW M
11 Jun 2026
SVP, Regulatory and Quality
Sold after exercise
30,000
$20.69
$620.82K
GREEN ANDREW M
11 Jun 2026
SVP, Regulatory and Quality
Sold after exercise
14,001
$20.71
$289.92K
Mackin James P
3 Dec 2025
President & CEO
Sold after exercise
30,921
$45.46
$1.41M
Mackin James P
2 Dec 2025
President & CEO
Sold after exercise
30,921
$45.56
$1.41M
Stanton Marshall S.
21 Nov 2025
SVP, Clinical & MD Affair
Sold after exercise
8,370
$45.35
$379.54K
Stanton Marshall S.
21 Nov 2025
SVP, Clinical & MD Affair
Sold after exercise
18,705
$44.91
$840.04K
Stanton Marshall S.
21 Nov 2025
SVP, Clinical & MD Affair
Sold after exercise
5,715
$45.35
$259.15K
Stanton Marshall S.
21 Nov 2025
SVP, Clinical & MD Affair
Sold after exercise
14,586
$44.92
$655.19K
Stanton Marshall S.
20 Nov 2025
SVP, Clinical & MD Affair
Sold after exercise
1,355
$44.28
$60.00K
Stanton Marshall S.
20 Nov 2025
SVP, Clinical & MD Affair
Sold after exercise
2,033
$44.32
$90.09K
Stanton Marshall S.
20 Nov 2025
SVP, Clinical & MD Affair
Sold after exercise
11,888
$44.14
$524.74K
Davis John E
17 Nov 2025
Chief Commercial Officer
Sold after exercise
6,394
$45.17
$288.82K
Holloway Jean F
17 Nov 2025
SVP, General Counsel
Sold after exercise
6,394
$45.17
$288.82K
Davis John E
14 Nov 2025
Chief Commercial Officer
Sold after exercise
6,393
$44.67
$285.58K
Holloway Jean F
14 Nov 2025
SVP, General Counsel
Sold after exercise
6,393
$45.00
$287.69K
Holloway Jean F
11 Nov 2025
SVP, General Counsel
Sold after exercise
10,000
$46.18
$461.80K
Stanton Marshall S.
27 Aug 2025
SVP, Clinical & MD Affair
Sold after exercise
18,200
$44.02
$801.22K
Holloway Jean F
25 Aug 2025
SVP, General Counsel
Sold after exercise
10,000
$44.37
$443.70K
Davis John E
12 Aug 2025
Chief Commercial Officer
Sold after exercise
10,802
$43.67
$471.76K
Holloway Jean F
12 Aug 2025
SVP, General Counsel
Sold after exercise
6,381
$43.02
$274.50K
Holloway Jean F
12 Aug 2025
SVP, General Counsel
Sold after exercise
16,975
$43.01
$730.11K
Horton Amy
8 Aug 2025
VP, Chief Accounting Officer
Sold after exercise
7,992
$38.49
$307.61K
Davis John E
11 Mar 2025
Chief Commercial Officer
Sold after exercise
15,100
$23.61
$356.55K
Holloway Jean F
11 Mar 2025
SVP, General Counsel
Sold after exercise
18,020
$23.61
$425.51K
Mackin James P
6 Mar 2025
President & CEO
Sold after exercise
70,700
$24.76
$1.75M
Mackin James P
6 Mar 2025
President & CEO
Sold after exercise
17,739
$24.80
$440.01K
Horton Amy
1 Oct 2024
VP, Chief Accounting Officer
Sold after exercise
12,430
$26.18
$325.41K
Mackin James P
20 Feb 2024
President & CEO
Sold after exercise
2,756
$18.87
$51.99K
Mackin James P
20 Feb 2024
President & CEO
Sold after exercise
10,088
$18.87
$190.31K
Mackin James P
20 Feb 2024
President & CEO
Sold after exercise
59,225
$18.85
$1.12M
Davis John E
2 Jan 2024
Senior VP, Global Sales
Sold after exercise
13,562
$18.00
$244.12K
Holloway Jean F
2 Jan 2024
SVP, General Counsel
Sold after exercise
21,229
$18.00
$382.12K
Horton Amy
15 Dec 2023
VP, Chief Accounting Officer
Sold after exercise
14,397
$19.00
$273.54K
Horton Amy
17 Feb 2023
VP, Chief Accounting Officer
Sold after exercise
3,000
$14.13
$42.39K
Horton Amy
17 Feb 2023
VP, Chief Accounting Officer
Sold after exercise
15,000
$14.08
$211.16K
Mackin James P
14 Feb 2023
President & CEO
Sold after exercise
56,500
$13.22
$747.21K
LEE DAVID ASHLEY
14 Feb 2023
Executive VP, COO & CFO
Sold after exercise
31,900
$13.22
$421.87K
Mackin James P
10 Feb 2022
President & CEO
Sold after exercise
10,639
$17.86
$190.00K
Mackin James P
9 Feb 2022
President & CEO
Sold after exercise
10,638
$18.14
$192.99K
Mackin James P
8 Feb 2022
President & CEO
Sold after exercise
10,638
$17.75
$188.77K
Mackin James P
7 Feb 2022
President & CEO
Sold after exercise
10,638
$17.30
$184.05K
Davis John E
25 May 2021
Senior VP, Global Sales
Sold after exercise
6,457
$29.65
$191.47K
Davis John E
25 May 2021
Senior VP, Global Sales
Sold after exercise
880
$29.70
$26.14K
Davis John E
25 May 2021
Senior VP, Global Sales
Sold after exercise
5,402
$29.67
$160.27K
Holloway Jean F
6 May 2021
SVP, General Counsel
Sold after exercise
6,618
$30.50
$201.85K
Horton Amy
6 May 2021
VP, Chief Accounting Officer
Sold after exercise
5,731
$30.00
$171.93K
Holloway Jean F
5 May 2021
SVP, General Counsel
Sold after exercise
6,618
$29.50
$195.23K
Horton Amy
5 May 2021
VP, Chief Accounting Officer
Sold after exercise
5,186
$30.00
$155.58K
LEE DAVID ASHLEY
5 May 2021
Executive VP, COO & CFO
Sold after exercise
27,242
$30.00
$817.26K
Horton Amy
30 Apr 2021
VP, Chief Accounting Officer
Sold after exercise
2,700
$30.00
$81.00K
LEE DAVID ASHLEY
30 Apr 2021
Executive VP, COO & CFO
Sold after exercise
6,800
$30.00
$204.00K
Mackin James P
30 Apr 2021
President & CEO
Sold after exercise
29,469
$28.00
$825.13K
Showing 250 of 344 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 602
Amendments (4/A) skipped 29
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 9
Sales straight out of an exercise 92
Sales at will 228
Transactions with no price 0
Shares from compensation/vesting 5,264,952
Sales filed before the plan box existed 86
History held since 13 Sep 2016